Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001415889-21-002666)

Filing Details

Accession Number:: 0001415889-21-002666
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-05-25 15:44:16
Reporting Period:: 2021-05-21

Accepted Time:: 2021-05-25 15:44:16
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1411906	Ampio Pharmaceuticals Inc.	AMPE	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1109775	H Philip Coelho	C/O Ampio Pharmaceuticals, Inc. 373 Inverness Parkway, Suite 200 Englewood CO 80112		No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-05-21	6,737	$0.40	210,237	No	4	M	Direct
Common Stock	Disposition	2021-05-21	6,737	$2.00	203,500	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2021-05-21	6,737	$0.00	6,737	$0.40

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2028-12-15	No	4	M	Direct

Footnotes

The option exercise reported on this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on March 30, 2021.
Options were granted and previously reported on a Form 4 filed on January 9, 2019, where the stock option vested and became exercisable in 12 equal monthly installments from the date of grant of December 15, 2018.